Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DAIZ is a Japanese biotechnology company specializing in the development of plant-based meat alternatives through its proprietary Ochiai Germination Method (OGM). By precisely controlling environmental factors such as temperature, oxygen, and carbon dioxide during the germination of soybeans, the company activates specific enzymes to enhance the flavor, texture, and nutritional profile of the beans. Their flagship product, Miracle Meat, is designed to mimic the characteristics of animal meat without the need for artificial additives or extensive processing. DAIZ collaborates with major food industry players to provide sustainable, high-quality protein solutions aimed at addressing global food security and environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DAIZ.